Nov. 14, 2013—On Jan. 1, 2014, hundreds of thousands of Tennesseans will become eligible for federally subsidized health insurance under the Affordable Care Act (ACA). Vanderbilt University Medical Center is launching a campaign to increase patient awareness about the ACA and help patients enroll in subsidized insurance plans.
Nov. 14, 2013—Vanderbilt graduate student Megan Capozzi has been named the Member-In-Training Board of Trustee to the Association for Research in Vision and Ophthalmology (ARVO).
Nov. 14, 2013—John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research.
Nov. 14, 2013—Vanderbilt University Medical Center staff and faculty are preparing for a new health care landscape, one shaped by a lowered payment regime, greater outside scrutiny of health care quality, new rewards and penalties for hospital and provider safety and quality, and the transfer of financial risk for health outcomes from payers to newly affiliated hospitals and providers.
Nov. 14, 2013—Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.
Nov. 14, 2013—As never before, large employers and regional health care providers have opportunity — and incentive — to work together to tame unsustainable health benefit cost inflation while improving health and health care outcomes.
Nov. 8, 2013—Clostridium difficile (“C. diff”) infection is a leading cause of hospital-associated diarrhea, and the frequency and severity of infections are on the rise. D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and colleagues recently demonstrated that the C. difficile toxin, TcdB, induces rapid cell death of human colon cell lines and pig colonic...
Nov. 7, 2013—Recent advances in robotics technology make it possible to create prosthetics that can duplicate the natural movement of human legs which promises to dramatically improve the mobility of lower-limb amputees.